<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-type="olc" bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-TAM21509-S68-W8-1S9"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>111 S777 IS: End Taxpayer Funding of Gender Experimentation Act of 2021</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2021-03-16</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>117th CONGRESS</congress><session>1st Session</session><legis-num>S. 777</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20210316">March 16, 2021</action-date><action-desc><sponsor name-id="S411">Mr. Marshall</sponsor> (for himself, <cosponsor name-id="S397">Mr. Braun</cosponsor>, <cosponsor name-id="S374">Mr. Cotton</cosponsor>, <cosponsor name-id="S396">Mrs. Blackburn</cosponsor>, <cosponsor name-id="S346">Mr. Lee</cosponsor>, and <cosponsor name-id="S395">Mrs. Hyde-Smith</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFI00">Committee on Finance</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes.</official-title></form><legis-body style="OLC" display-enacting-clause="yes-display-enacting-clause" id="H512DAF93215E4A909F6B7B2B90097D6F"><section section-type="section-one" id="H523D038023844F3083EEEC84909926C5"><enum>1.</enum><header>Short title; table of contents</header><subsection id="H94150F4101E64B70BA6A449F6F05B648"><enum>(a)</enum><header>Short title</header><text display-inline="yes-display-inline">This Act may be cited as the <quote><short-title>End Taxpayer Funding of Gender Experimentation Act of 2021</short-title></quote>.</text></subsection><subsection id="H1AA5F574E8314F9E98EE7C13CC5644DC"><enum>(b)</enum><header>Table of contents</header><text>The table of contents of this Act is as follows:</text><toc container-level="legis-body-container" lowest-bolded-level="division-lowest-bolded" lowest-level="section" quoted-block="no-quoted-block" regeneration="yes-regeneration"><toc-entry idref="H523D038023844F3083EEEC84909926C5" level="section">Sec. 1. Short title; table of contents.</toc-entry><toc-entry idref="HC37FE777AEF64780B508E083947D4382" level="title">Title I—Prohibiting Federally Funded Gender Reassignment Medical Interventions</toc-entry><toc-entry idref="H52B7D4371E114F0EAFE91E16D7BCD160" level="section">Sec. 101. Prohibiting taxpayer-funded gender reassignment medical interventions.</toc-entry><toc-entry idref="HA95543D479B24850A00F415BE49255DB" level="section">Sec. 102. Amendment to table of chapters.</toc-entry><toc-entry idref="H642E2FAF8A01448586AFAEC8EAC098D3" level="title">Title II—Application under the Affordable Care Act</toc-entry><toc-entry idref="H0DE80340EC61478EA6649B070AEA1BCC" level="section">Sec. 201. Clarifying application of prohibition to premium credits and cost-sharing reductions under ACA.</toc-entry></toc></subsection></section><title id="HC37FE777AEF64780B508E083947D4382"><enum>I</enum><header>Prohibiting Federally Funded Gender Reassignment Medical Interventions</header><section id="H52B7D4371E114F0EAFE91E16D7BCD160"><enum>101.</enum><header>Prohibiting taxpayer-funded gender reassignment medical interventions</header><text display-inline="no-display-inline">Title 1, United States Code, is amended by adding at the end the following new chapter:</text><quoted-block style="USC" display-inline="no-display-inline" id="HCD7D56C57E844E7EAA171A2CA40CCFDC"><chapter id="H2D6D7BC1808F4DD2AE75FFE3A6E27517"><enum>4</enum><header>Prohibiting taxpayer-funded gender reassignment medical interventions</header><toc container-level="chapter-container" idref="H2D6D7BC1808F4DD2AE75FFE3A6E27517" lowest-bolded-level="division-lowest-bolded" lowest-level="section" quoted-block="no-quoted-block" regeneration="yes-regeneration"><toc-entry idref="HA07074918092475091E3EAF2AC1C39B6" level="section">301. Prohibition on funding for gender reassignment medical interventions.</toc-entry><toc-entry idref="H195BC353E3E443E1A77779D73C740F8A" level="section">302. Prohibition on funding for health benefits plans that cover gender reassignment medical interventions.</toc-entry><toc-entry idref="H39127A4AA4324232A427209B0CF20A59" level="section">303. Limitation on Federal facilities and employees.</toc-entry><toc-entry idref="HB672573A8BDB4BDEA74C40B6554FCB7B" level="section">304. Construction relating to separate coverage.</toc-entry><toc-entry idref="H6CB9520898244D3B8531BF311FC34376" level="section">305. Construction relating to the use of non-Federal funds for health coverage.</toc-entry><toc-entry idref="HA5B2E8930C7F475A8D139ECABC2A3F9F" level="section">306. Construction relating to complications arising from gender reassignment medical interventions.</toc-entry><toc-entry idref="H30E1A086E7CE45B1A0D83A33CC3BA005" level="section">307. Treatment of individuals born with medically verifiable disorder of sex development.</toc-entry><toc-entry idref="HB118F4BA1FCC43C19DDEC48968FD9D39" level="section">308. Gender reassignment medical intervention defined.</toc-entry></toc><section id="HA07074918092475091E3EAF2AC1C39B6"><enum>301.</enum><header>Prohibition on funding for gender reassignment medical interventions</header><text display-inline="no-display-inline">No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender reassignment medical intervention.</text></section><section id="H195BC353E3E443E1A77779D73C740F8A"><enum>302.</enum><header>Prohibition on funding for health benefits plans that cover gender reassignment medical interventions</header><text display-inline="no-display-inline">No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender reassignment medical interventions.</text></section><section id="H39127A4AA4324232A427209B0CF20A59"><enum>303.</enum><header>Limitation on Federal facilities and employees</header><text display-inline="no-display-inline">No health care service furnished—</text><paragraph id="H5A4B7A956E344E84802395D62EE12BDA"><enum>(1)</enum><text>by or in a health care facility owned or operated by the Federal Government; or</text></paragraph><paragraph id="H851FA455E9BC4334B645098FF8477DBA"><enum>(2)</enum><text>by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment,</text></paragraph><continuation-text continuation-text-level="section">may include gender reassignment medical interventions.</continuation-text></section><section id="HB672573A8BDB4BDEA74C40B6554FCB7B"><enum>304.</enum><header>Construction relating to separate coverage</header><text display-inline="no-display-inline">Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender reassignment medical interventions or health benefits coverage that includes gender reassignment medical interventions so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds.</text></section><section id="H6CB9520898244D3B8531BF311FC34376"><enum>305.</enum><header>Construction relating to the use of non-Federal funds for health coverage</header><text display-inline="no-display-inline">Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender reassignment medical interventions, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds.</text></section><section id="HA5B2E8930C7F475A8D139ECABC2A3F9F"><enum>306.</enum><header>Construction relating to complications arising from gender reassignment medical interventions</header><text display-inline="no-display-inline">Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender reassignment medical intervention. This rule of construction shall be applicable without regard to whether the gender reassignment medical intervention was performed in accord with Federal or State law, and without regard to whether funding for the gender reassignment medical intervention is permissible under section 307.</text></section><section id="H30E1A086E7CE45B1A0D83A33CC3BA005"><enum>307.</enum><header>Treatment of individuals born with medically verifiable disorder of sex development</header><text display-inline="no-display-inline">The limitations established in sections 301, 302, and 303 shall not apply with respect to the following individuals:</text><paragraph id="H3653405CFE58419EB3A49A79E79233ED"><enum>(1)</enum><text display-inline="yes-display-inline">An individual with external biological sex characteristics that are irresolvably ambiguous, such as those born with 46 XX chromosomes with virilization, 46 XY chromosomes with undervirilization, or having both ovarian and testicular tissue.</text></paragraph><paragraph id="H6350C4F0E65344B2802DA8C911433575"><enum>(2)</enum><text display-inline="yes-display-inline">An individual with respect to whom a physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a biological male or female.</text></paragraph></section><section id="HB118F4BA1FCC43C19DDEC48968FD9D39"><enum>308.</enum><header>Gender reassignment medical intervention defined</header><text display-inline="no-display-inline">For purposes of this chapter, the term <term>gender reassignment medical intervention</term> means—</text><paragraph id="H1EF5BAA58F4B4E8191538847BEE3833C"><enum>(1)</enum><text display-inline="yes-display-inline">performing a surgery that sterilizes an individual, including castration, vasectomy, hysterectomy, oophorectomy, metoidioplasty, penectomy, phalloplasty, and vaginoplasty, to change the body of such individual to correspond to a sex that is discordant with biological sex;</text></paragraph><paragraph id="H756C49D82E164C72AD386150828B89F1"><enum>(2)</enum><text>performing a mastectomy on an individual for the purpose described in paragraph (1); and</text></paragraph><paragraph id="HF08B3B3CA2284C839C97FA2958A8DCFF"><enum>(3)</enum><text>administering or supplying to an individual medications for the purpose described in paragraph (1), including—</text><subparagraph id="H636CA0A37A9D4E5AAB120BEC77FFBFE8"><enum>(A)</enum><text display-inline="yes-display-inline">GnRH agonists or other puberty-blocking drugs to stop or delay normal puberty;</text></subparagraph><subparagraph id="H7F9D143573D04CDAAD134D9985C22BE8"><enum>(B)</enum><text>testosterone or other androgens to biological females at doses that are supraphysiologic to the female sex; and</text></subparagraph><subparagraph id="H5A527C71A25E46A79B379662E99ED19C"><enum>(C)</enum><text>estrogen to biological males at doses that are supraphysiologic to the male sex.</text></subparagraph></paragraph></section></chapter><after-quoted-block>.</after-quoted-block></quoted-block></section><section id="HA95543D479B24850A00F415BE49255DB"><enum>102.</enum><header>Amendment to table of chapters</header><text display-inline="no-display-inline">The table of chapters for title 1, United States Code, is amended by adding at the end the following new item:</text><quoted-block style="USC" display-inline="no-display-inline" id="HAFEEA1F380AB498D8B0F87E0BDCE21B4"><toc regeneration="no-regeneration"><multi-column-toc-entry bold="on" level="section"><toc-enum>4.</toc-enum><level-header bold="on" level="section">Prohibiting taxpayer-funded gender reassignment medical interventions</level-header><target>301</target></multi-column-toc-entry></toc><after-quoted-block>.</after-quoted-block></quoted-block></section></title><title id="H642E2FAF8A01448586AFAEC8EAC098D3"><enum>II</enum><header>Application under the Affordable Care Act</header><section id="H0DE80340EC61478EA6649B070AEA1BCC"><enum>201.</enum><header>Clarifying application of prohibition to premium credits and cost-sharing reductions under ACA</header><subsection display-inline="no-display-inline" id="H6B42E1EC68394AAAAC74D3FCA14FA996"><enum>(a)</enum><header>In general</header><paragraph id="H37BAEB6C8860482A834A4C1858E3A49F"><enum>(1)</enum><header>Disallowance of refundable credit and cost-sharing reductions for coverage under qualified health plan which provides coverage for gender reassignment medical interventions</header><subparagraph id="H7E28F811940C4447983D28DD80CD1914"><enum>(A)</enum><header>In general</header><text>Subparagraph (A) of <external-xref legal-doc="usc" parsable-cite="usc/26/36B">section 36B(c)(3)</external-xref> of the Internal Revenue Code of 1986 is amended by inserting before the period at the end the following: <quote>or any health plan that includes coverage for gender reassignment medical interventions (other than any gender reassignment medical intervention or treatment described in section 306 or 307 of title 1, United States Code)</quote>.</text></subparagraph><subparagraph id="H690F5E3CDA9349749F96BB5469F6F0A7"><enum>(B)</enum><header>Option to purchase or offer separate coverage or plan</header><text display-inline="yes-display-inline">Paragraph (3) of section 36B(c) of such Code is amended by adding at the end the following new subparagraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HA3726A2D89804EF0A7661BF34298BEA6"><subparagraph id="H1FDD7EE2C3B64D6DBAD610252DE7E1EB"><enum>(C)</enum><header>Separate coverage or plan for gender reassignment medical interventions allowed</header><clause id="HE45BAC6CE2A8463DBD06F3933B3E12B1"><enum>(i)</enum><header>Option to purchase separate coverage or plan</header><text display-inline="yes-display-inline">Nothing in subparagraph (A) shall be construed as prohibiting any individual from purchasing separate coverage for gender reassignment medical interventions described in such subparagraph, or a health plan that includes such gender reassignment medical interventions, so long as no credit is allowed under this section with respect to the premiums for such coverage or plan.</text></clause><clause id="H60CB4EC4E2DF414FB2F6EC8685305816"><enum>(ii)</enum><header>Option to offer coverage or plan</header><text display-inline="yes-display-inline">Nothing in subparagraph (A) shall restrict any non-Federal health insurance issuer offering a health plan from offering separate coverage for gender reassignment medical interventions described in such subparagraph, or a plan that includes such gender reassignment medical interventions, so long as premiums for such separate coverage or plan are not paid for with any amount attributable to the credit allowed under this section (or the amount of any advance payment of the credit under section 1412 of the Patient Protection and Affordable Care Act).</text></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="H7D9C27C513D3420AB6D3BBC39ADBB5DC"><enum>(2)</enum><header>Disallowance of small employer health insurance expense credit for plan which includes coverage for gender reassignment medical interventions</header><text>Subsection (h) of <external-xref legal-doc="usc" parsable-cite="usc/26/45R">section 45R</external-xref> of the Internal Revenue Code of 1986 is amended—</text><subparagraph display-inline="no-display-inline" id="H7F9FC83392FD4064A995D97D0DEB7D3D"><enum>(A)</enum><text>by striking <quote>Any term</quote> and inserting the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H830165352A784DEEB5AEF04A322D6312"><paragraph id="H644383919A8D41A1B4314EE826B13B6C"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Any term</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph><subparagraph id="H5A051F72AA914D0BA1762210FE487D9D"><enum>(B)</enum><text>by adding at the end the following new paragraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H3C913A111B7041DD977B821ABE31033E"><paragraph id="HA82D0E5ED5B64CF08605AF4F0BC5D176"><enum>(2)</enum><header>Exclusion of health plans including coverage for gender reassignment medical interventions</header><subparagraph id="HD2F80CFCF6BE416CABBC945287168603"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">The term <term>qualified health plan</term> does not include any health plan that includes coverage for gender reassignment medical interventions (other than any gender reassignment medical intervention or treatment described in section 306 or 307 of title 1, United States Code).</text></subparagraph><subparagraph id="H633B515D7B4547C3AA9B25F7ABA8C388"><enum>(B)</enum><header>Separate coverage or plan for gender reassignment medical interventions allowed</header><clause display-inline="no-display-inline" id="H61A805050D054F258CD39774AF7C2589"><enum>(i)</enum><header>Option to purchase separate coverage or plan</header><text display-inline="yes-display-inline">Nothing in subparagraph (A) shall be construed as prohibiting any employer from purchasing for its employees separate coverage for gender reassignment medical interventions described in such subparagraph, or a health plan that includes such gender reassignment medical interventions, so long as no credit is allowed under this section with respect to the employer contributions for such coverage or plan.</text></clause><clause id="H53CF98624B674DDD9B0CDB339D68A174"><enum>(ii)</enum><header>Option to offer coverage or plan</header><text display-inline="yes-display-inline">Nothing in subparagraph (A) shall restrict any non-Federal health insurance issuer offering a health plan from offering separate coverage for gender reassignment medical interventions described in such subparagraph, or a plan that includes such gender reassignment medical interventions, so long as such separate coverage or plan is not paid for with any employer contribution eligible for the credit allowed under this section.</text></clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph></subsection><subsection id="H2DDB1BAC2ED645D49C86323BB4250033"><enum>(b)</enum><header>Application to multi-State plans</header><text>Section 1334(a) of <external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref> (<external-xref legal-doc="usc" parsable-cite="usc/42/18054">42 U.S.C. 18054(a)</external-xref>) is amended by adding at the end the following new paragraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HE4D1F5923F6C49D8AF184D18C4D4EDCC"><paragraph id="H1FEE24B6C9D842E69F6B97CDFE494033"><enum>(8)</enum><header>Coverage consistent with Federal policy regarding gender reassignment medical interventions</header><text display-inline="yes-display-inline">In entering into contracts under this subsection, the Director shall ensure that no multi-State qualified health plan offered in an Exchange provides health benefits coverage for which the expenditure of Federal funds is prohibited under <external-xref legal-doc="usc-chapter" parsable-cite="usc-chapter/1/4">chapter 4</external-xref> of title 1, United States Code.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HF9EEEF7612E24689B6BD8DCA764A01BD"><enum>(c)</enum><header>Effective date</header><text display-inline="yes-display-inline">The amendments made by subsection (a) shall apply to taxable years ending after the date that is one year after the date of enactment of this Act, but only with respect to plan years beginning after such date, and the amendment made by subsection (b) shall apply to plan years beginning after such date.</text></subsection></section></title></legis-body></bill> 

